Related Experiment Video
Updated: Aug 4, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Why Diverse Clinical Trial Participation Matters
Aaron L Schwartz1, Marcella Alsan1, Alanna A Morris1
1From the Department of Medical Ethics and Health Policy (A.L.S., S.D.H.) and the Behavioral Economics to Transform Trial Enrollment Representativeness (BETTER) Center (A.A.M., S.D.H.), Perelman School of Medicine, University of Pennsylvania, and the Center for Health Equity Research and Promotion, Department of Veterans Affairs (A.L.S.) - both in Philadelphia; the Harvard Kennedy School of Government and the National Bureau of Economic Research - both in Cambridge, MA (M.A.); and the Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta (A.A.M.).
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Preclinical Development: Overview

